Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

about

IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model

P2860

Q57136724-8C478E8D-0BF9-40BD-BD51-0BB1312D73AF

P2860

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

Item

http://www.wikidata.org/entity/Q42374948

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@en

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@nl

type

Item

label

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@en

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@nl

prefLabel

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@en

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@nl

P1476

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

@en

P2093

Austin J Schults

http://www.w3.org/2001/XMLSchema#string

Glenn D Prestwich

http://www.w3.org/2001/XMLSchema#string

Jeremiah A Alt

http://www.w3.org/2001/XMLSchema#string

Mark Martin Jensen

http://www.w3.org/2001/XMLSchema#string

Siam Oottamasathien

http://www.w3.org/2001/XMLSchema#string

Wanjian Jia

http://www.w3.org/2001/XMLSchema#string

Xiangyang Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review.

Treatment of painful bladder syndrome/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients?

Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on Internet search activity by the public

Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis.

Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan

LL-37 induced cystitis and the receptor for advanced glycation end-products (RAGE) pathway.

Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Mast cell involvement in interstitial cystitis: a review of human and experimental evidence.

Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.

Epidemiology of interstitial cystitis.

P304

10-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29034266

http://www.w3.org/2001/XMLSchema#string

P932

5636891

http://www.w3.org/2001/XMLSchema#string

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

about

P2860

P2860

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932